BNP PARIBAS FINANCIAL MARKETS - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$175,115,836,000
+0.6%
4,022,877
+0.7%
0.27%
+16.7%
Q1 2022$174,067,372,000
+2.0%
3,996,037
+3.3%
0.23%
-3.7%
Q4 2021$170,673,747,000
-25.6%
3,870,153
-35.6%
0.24%
-25.2%
Q3 2021$229,454,451,000
-4.1%
6,005,089
-0.1%
0.32%
+2.5%
Q2 2021$239,367,179,000
+51594.5%
6,011,230
+46232.9%
0.32%
+31600.0%
Q1 2021$463,042,000
-73.7%
12,974
-72.8%
0.00%
-66.7%
Q4 2020$1,757,899,000
+405.2%
47,769
+416.8%
0.00%
Q3 2020$347,944,000
-11.8%
9,244
-4.4%
0.00%
-100.0%
Q2 2020$394,358,000
+42.0%
9,668
+31.9%
0.00%0.0%
Q1 2020$277,658,000
-84.5%
7,328
-80.8%
0.00%
-66.7%
Q4 2019$1,794,783,000
-50.4%
38,195
-54.9%
0.00%
-50.0%
Q3 2019$3,615,380,000
+26.4%
84,709
+18.5%
0.01%0.0%
Q2 2019$2,860,109,000
-8.9%
71,467
-4.9%
0.01%
-14.3%
Q1 2019$3,140,351,000
+169.8%
75,146
+146.7%
0.01%
+133.3%
Q4 2018$1,163,838,000
-39.8%
30,459
-36.7%
0.00%0.0%
Q3 2018$1,931,976,000
+6.6%
48,095
+7.0%
0.00%0.0%
Q2 2018$1,812,499,000
-13.5%
44,964
-16.2%
0.00%
-25.0%
Q1 2018$2,095,793,000
-7.9%
53,642
-16.3%
0.00%0.0%
Q4 2017$2,274,407,000
-45.3%
64,122
-37.3%
0.00%
-60.0%
Q3 2017$4,154,638,000
-9.2%
102,331
-3.6%
0.01%
-28.6%
Q2 2017$4,576,455,000
-5.1%
106,133
-7.2%
0.01%
+7.7%
Q1 2017$4,824,327,000
+29.4%
114,429
+18.2%
0.01%
-23.5%
Q4 2016$3,727,652,000
-44.8%
96,797
-38.2%
0.02%
-39.3%
Q3 2016$6,754,244,000
+9.6%
156,602
+10.1%
0.03%0.0%
Q2 2016$6,164,422,000
+9.2%
142,234
+2.2%
0.03%
+16.7%
Q1 2016$5,643,060,000
+26.1%
139,163
+25.5%
0.02%
+118.2%
Q4 2015$4,474,330,000
+20.0%
110,888
+14.3%
0.01%
+22.2%
Q3 2015$3,729,804,000
-50.1%
97,004
-46.0%
0.01%
-57.1%
Q2 2015$7,477,466,000
+179.1%
179,531
+209.3%
0.02%
+200.0%
Q1 2015$2,678,731,000
-38.2%
58,044
-42.7%
0.01%
-53.3%
Q4 2014$4,333,024,000
-6.9%
101,381
+0.4%
0.02%
+275.0%
Q3 2014$4,653,758,000
+665.6%
100,968
+758.2%
0.00%
+300.0%
Q2 2014$607,878,000
-8.5%
11,765
-2.0%
0.00%0.0%
Q1 2014$664,661,000
+16.9%
12,004
+12.8%
0.00%
Q4 2013$568,390,000
-97.8%
10,646
-98.0%
0.00%
-100.0%
Q3 2013$26,270,800,000
+7871.7%
523,635
+7839.9%
0.02%
Q2 2013$329,552,0006,5950.00%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders